
Floy GmbH is a Munich-based health technology company founded in 2021 that combines human and artificial intelligence to enhance healthcare outcomes. Their business model centers on AI-powered diagnostic software that supports radiologists in detecting difficult-to-diagnose abnormalities in radiological images, improving early detection of diseases such as aneurysms, dementia, multiple sclerosis, malignant bone lesions, and breast cancer. Floy offers certified medical AI products licensed by ISO13485:2016-certified providers and operates through partnerships with radiology practices, currently used by over 200 radiology offices. Their solutions include FloyRadiology, which provides AI-assisted second opinions for radiological images, and FloyZone, a preventive health center offering comprehensive health assessments. The company emphasizes patient safety, data privacy, and scientific rigor, collaborating with leading global research institutions. Floy has gained significant traction with rapid expansion into 170 practices within a year and has secured substantial funding. It is recognized as an innovator in digital health and AI in radiology, positioning itself as a leader in proactive, AI-enhanced medical diagnostics in Germany and Europe.

Floy GmbH is a Munich-based health technology company founded in 2021 that combines human and artificial intelligence to enhance healthcare outcomes. Their business model centers on AI-powered diagnostic software that supports radiologists in detecting difficult-to-diagnose abnormalities in radiological images, improving early detection of diseases such as aneurysms, dementia, multiple sclerosis, malignant bone lesions, and breast cancer. Floy offers certified medical AI products licensed by ISO13485:2016-certified providers and operates through partnerships with radiology practices, currently used by over 200 radiology offices. Their solutions include FloyRadiology, which provides AI-assisted second opinions for radiological images, and FloyZone, a preventive health center offering comprehensive health assessments. The company emphasizes patient safety, data privacy, and scientific rigor, collaborating with leading global research institutions. Floy has gained significant traction with rapid expansion into 170 practices within a year and has secured substantial funding. It is recognized as an innovator in digital health and AI in radiology, positioning itself as a leader in proactive, AI-enhanced medical diagnostics in Germany and Europe.
Headquarters: Munich, Germany
Founded: 2021
Core product: AI-powered radiology diagnostic/second-opinion software
Customers / traction: Used by radiology practices (170+ practices / 200+ offices reported)
Recent funding: Seed round announced Feb 14, 2025; investors include Acurio Ventures and HV Capital
| Company |
|---|
Radiology diagnostics and preventive health monitoring using medical AI
2021
Data and Analytics
Latest disclosed round per company records
“Investors include Acurio Ventures, HV Capital, 10x Founders, Saarbruecker 21, xdeck”